[1] Zhao Q, Hu P, Li Q Q, et al. Prevalence and transmission characteristics of Listeria species from ruminants in farm and slaughtering environments in China[J]. Emerg Microbes Infect, 2021, 10(1):356-364. DOI:10.1080/22221751.2021.1888658. [2] Giralt-Zúñiga M, Redondo-Solano M, Moura A, et al. Genome-based characterization of Listeria monocytogenes, costa rica[J]. Emerg Infect Dis, 2023, 29(12):2566-2569.. DOI:10.3201/eid2912.230774. [3] Mayer R L, Verbeke R, Asselman C, et al. Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes[J]. Nat Commun, 2022, 13:6075. DOI:10.1038/s41467-022-33721-y. [4] Charlier C, Disson O, Lecuit M. Maternal-neonatal listeriosis[J]. Virulence, 2020, 11(1):391-397. DOI:10.1080/21505594.2020.1759287. [5] Gattuso A, Cella E, Fillo S, et al. Phylogenetic and evolutionary genomic analysis of Listeria monocytogenes clinical strains in the framework of foodborne listeriosis risk assessment[J]. Front Microbiol, 2022, 13:816880. DOI:10.3389/fmicb.2022.816880. [6] Koopmans M M, Brouwer M C, Vázquez-Boland J A, et al. Human listeriosis[J]. Clin Microbiol Rev, 2023, 36:e00060-e00019. DOI:10.1128/cmr.00060-19. [7] Soria-Castro R, Alfaro-Doblado á R, Rodríguez-López G, et al. TLR2 regulates mast cell IL-6 and IL-13 production during Listeria monocytogenes infection[J]. Front Immunol, 2021, 12:650779. DOI:10.3389/fimmu.2021.650779. [8] Tan J M J, Garner M E, Regeimbal J M, et al. Listeria exploits IFITM3 to suppress antibacterial activity in phagocytes[J]. Nat Commun, 2021, 12:4999. DOI:10.1038/s41467-021-24982-0. [9] Schlech W F III. Epidemiology and clinical manifestations of Listeria monocytogenes infection[J]. Microbiol Spectr, 2019, 7(3):7.3.3. DOI:10.1128/microbiolspec.gpp3-0014-2018. [10] Bookstaver P B, Bland C M, Griffin B, et al. A review of antibiotic use in pregnancy[J]. Pharmacotherapy, 2015, 35(11):1052-1062. DOI:10.1002/phar.1649. [11] Rocha C E V, Silva M F, Guedes A C B, et al. Alginate-chitosan microcapsules improve vaccine potential of gamma-irradiated Listeria monocytogenes against listeriosis in murine model[J]. Int J Biol Macromol, 2021, 176:567-577. DOI:10.1016/j.ijbiomac.2021.02.056. [12] Kew O, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus[J]. Science, 2002, 296(5566):356-359. DOI:10.1126/science.1068284. [13] Yan Y R, Zhang L, Lin Y N, et al. Chronic intermittent hypoxia-induced mitochondrial dysfunction mediates endothelial injury via the TXNIP/NLRP3/IL-1β signaling pathway[J]. Free Radic Biol Med, 2021, 165:401-410. DOI:10.1016/j.freeradbiomed.2021.01.053. [14] Huang J H, Zhang X Y, Yang X P, et al. Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson’s disease[J]. Chem Biol Interact, 2024, 387:110820. DOI:10.1016/j.cbi.2023.110820. [15] Wei X H, Zhang B P, Wei F Y, et al. Gegen Qinlian pills alleviate carrageenan-induced thrombosis in mice model by regulating the HMGB1/NF-κB/NLRP3 signaling[J]. Phytomedicine, 2022, 100:154083. DOI:10.1016/j.phymed.2022.154083. [16] 钱秋然,王杰平,张艳荣,等.基于PI3K/Akt信号通路探讨黄芩苷调节复发性流产小鼠子宫母胎界面免疫状态的影响[J].中医药信息, 2022, 39(8):8-13. DOI:10.19656/j.cnki.1002-2406.20220802. [17] Wu Y L, Wang F, Fan L H, et al. Baicalin alleviates atherosclerosis by relieving oxidative stress and inflammatory responses via inactivating the NF-κB and p38 MAPK signaling pathways[J]. Biomed Pharmacother, 2018, 97:1673-1679. DOI:10.1016/j.biopha.2017.12.024. [18] Fu Y J, Xu B, Huang S W, et al. Baicalin prevents LPS-induced activation of TLR4/NF-κB p65 pathway and inflammation in mice via inhibiting the expression of CD14[J]. Acta Pharmacol Sin, 2021, 42(1):88-96. DOI:10.1038/s41401-020-0411-9. [19] 刘雯,张恩华,陈滢滢,等.黄芩苷对单增李斯特菌诱导巨噬细胞炎性小体激活的抑制作用[J].河北大学学报(自然科学版), 2024, 44(4):399-405. DOI: 10.3969/j.issn.1000-1565.2024.04.008. [20] 魏滋鸿.黄芩提取物抗单增李斯特菌感染的作用的研究[D].长春:吉林大学, 2018. [21] Karakaslar E O, Katiyar N, Hasham M, et al. Transcriptional activation of Jun and Fos members of the AP-1 complex is a conserved signature of immune aging that contributes to inflammaging[J]. Aging Cell, 2023, 22(4):e13792. DOI:10.1111/acel.13792. [22] Song D D, Lian Y, Zhang L. The potential of activator protein 1(AP-1)in cancer targeted therapy[J]. Front Immunol, 2023, 14:1224892. DOI:10.3389/fimmu.2023.1224892. [23] Zhang C, Yu M M, Hepperla A J, et al. Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis[J]. J Clin Investig, 2024, 134(8):e175703. DOI:10.1172/jci175703. [24] Esen I, Sandovici M, Heeringa P, et al. Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis[J]. J Autoimmun, 2024, 146:103215. DOI:10.1016/j.jaut.2024.103215. [25] Cheng D M, Lian W X, Wang T, et al. The interplay of Cxcl10+/Mmp14+ monocytes and Ccl3+ neutrophils proactively mediates silica-induced pulmonary fibrosis[J]. J Hazard Mater, 2024, 467:133713. DOI:10.1016/j.jhazmat.2024.133713. [26] Chang T T, Lin L Y, Chen C, et al. CCL4 contributes to aging related angiogenic insufficiency through activating oxidative stress and endothelial inflammation[J]. Angiogenesis, 2024, 27(3):475-499. DOI:10.1007/s10456-024-09922-y. [27] Chen R, Yang X, Liu Q, et al. Research progresses on the effects of CCL4 on immune escape in tumor microenvironment[J]. Chin J Lung Cancer, 2024, 27(8):613-621. doi:10.3779/j.issn.1009-3419.2024.106.23. [28] Tang J T, Gao K C, Zhang Y, et al. ERK/STAT3 activation through CCL17/CCR4 axis-mediated type 2 cytokine-involved signaling pathways in Th2 cells regulates cutaneous drug reactions[J]. Int Immunopharmacol, 2024, 130:111712. DOI:10.1016/j.intimp.2024.111712. [29] Yue S Y, Niu D, Ma W M, et al. The CXCL10/CXCR3 axis regulates Th1 cell differentiation and migration in experimental autoimmune prostatitis through the PI3K/AKT pathway[J]. Andrology, 2024, 12(6):1408-1418. DOI:10.1111/andr.13571. [30] Rosain J, Neehus A L, Manry J, et al. Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria[J]. Cell, 2023, 186(3):621-645.e33. DOI:10.1016/j.cell.2022.12.038. [31] Ahn B Y, Zhang Y, Wei S B, et al. Prmt7 regulates the JAK/STAT/Socs3 signaling pathway in postmenopausal cardiomyopathy[J]. Exp Mol Med, 2024, 56(3):711-720. DOI:10.1038/s12276-024-01193-3. [32] Yan D M, Li G N, Yuan Y, et al. SOCS3 inhibiting JAK-STAT pathway enhances oncolytic adenovirus efficacy by potentiating viral replication and T-cell activation[J]. Cancer Gene Ther, 2024, 31(3):397-409. DOI:10.1038/s41417-023-00710-2. [33] Zanders L, Kny M, Hahn A, et al. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting[J]. J Cachexia Sarcopenia Muscle, 2022, 13(1):713-727. DOI:10.1002/jcsm.12867. ( |